A Trial of Degarelix in Men With Lower Urinary Tract Symptoms (LUTS) Associated With Benign Prostatic Hyperplasia (BPH)
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A dose-finding, multi-centre, double-blind, randomised, parallel, placebo-controlled trial to
investigate efficacy and safety of degarelix in men with lower urinary tract symptoms (LUTS)
associated with benign prostatic hyperplasia (BPH)